Cerner to Streamline Electronic Health Record at Alabama Health System

NEXT STORY
Aptevo Announces Pricing of $22 Million Offering of Common Stock and Warrants
PREV STORY
Roche submits supplemental new drug application to FDA for Venclexta plus Gazyva for previously untreated chronic lymphocytic leukaemia with co-existing medical conditions
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Revelation Biosciences Inc. Announces First Patient Enrolled and Dosed in Phase 1b Clinical Study of REVTx-99 for the Treatment of Allergic Rhinitis

author_avatar
NASDAQ Market News

Onconova Enrolls First Patient in Europe for Phase 3 INSPIRE Trial of Rigosertib in Higher-Risk Myelodysplastic Syndromes

NEWTOWN, Pa., March 21, 2016 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a clinical-stage ...

author_avatar
NASDAQ Market News

Global DNA Vaccine Market Outlook, 2022 – Major Players are GlaxoSmithKline’s Engerix-B, Twinrix, and Fendrix; Merck’s Gardasil, and Recombivax HB

Dublin, June 19, 2018 (GLOBE NEWSWIRE) -- The "Global DNA Vaccine Market Outlook 2018-2022" ...

author_avatar
NASDAQ Market News